The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease

Journal of the American Society of Nephrology

Volumn 13, Issue 11, 2002, Pages 2723-2729

  Belibi, Franck A ^a   Wallace, Darren P ^a   Yamaguchi, Tamio ^a   Christensen, Marcy ^a   Reif, Gail ^a   Grantham, Jared J ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENYLATE CYCLASE; CAFFEINE; CYCLIC AMP; DESMOPRESSIN; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN E2; ROLIPRAM; THEOPHYLLINE;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; KIDNEY CORTEX; KIDNEY EPITHELIUM; KIDNEY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RISK FACTOR; SECRETION; WESTERN BLOTTING;

EID: 0036838373     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000025282.48298.7B     Document Type: Article

References (37)

1. Calvet JP, Grantham JJ: The genetics and physiology of polycystic kidney disease. Semin Nephrol 21: 107-123, 2001
2. Sullivan LP, Wallace DP, Grantham JJ: Epithelial transport in polycystic kidney disease. Physiol Rev 78: 1165-1191, 1998
3. Sullivan LP, Wallace DP, Grantham JJ: Chloride and fluid secretion in polycystic kidney disease. J Am Soc Nephrol 9: 903-916, 1998
4. Yamaguchi T, Pelling JC, Ramaswamy NT, Eppler JW, Wallace DP, Nagao S, Rome LA, Sullivan LP, Grantham JJ: cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int 57: 1460-1471, 2000
5. Dousa TP: Cyclic-3′,5′-nucleotide phosphodiesterases in the cyclic adenosine monophosphate (cAMP)-mediated actions of vasopressin. Semin Nephrol 14: 333-340, 1994
6. Grantham JJ: Renal cell proliferation and the two faces of cyclic adenosine monophosphate. J Lab Clin Med 130: 459-460, 1997
7. Tanner GA, Tanner JA: Chronic caffeine consumption exacerbates hypertension in rats with polycystic kidney disease. Am J Kidney Dis 38: 1089-1095, 2001
8. Wallace DP, Grantham JJ, Sullivan LP: Chloride and fluid secretion by cultured human polycystic kidney cells. Kidney Int 50: 1327-1336, 1996
9. Davidow CJ, Maser RL, Rome LA, Calvet JP, Grantham JJ: The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro. Kidney Int 50: 208-218, 1996
10. Mangoo-Karim R, Ye M, Wallace DP, Grantham JJ, Sullivan LP: Anion secretion drives fluid secretion by monolayers of cultured human polycystic cells. Am J Physiol 269: F381-F388, 1995
11. Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE: Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 51: 83-133, 1999
12. Birkett DJ, Miners JO: Caffeine renal clearance and urine caffeine concentrations during steady state dosing. Implications for monitoring caffeine intake during sports events. Br J Clin Pharmacol 31: 405-408, 1991
13. Cook DG, Peacock JL, Feyerabend C, Carey IM, Jarvis MJ, Anderson HR, Bland JM: Relation of caffeine intake and blood caffeine concentrations during pregnancy to fetal growth: Prospective population based study. BMJ 313: 1358-1362, 1996
14. Ambrogio GS, Mognoni P, Ventrella L: Plasma levels of caffeine after oral, intramuscular and intravenous administration. Arch Int Pharmacodyn 149: 259-263, 1964
15. Chen JF, Xu K, Petzer JP, Staal R, Xu YH, Beilstein M, Sonsalla PK, Castagnoli K, Castagnoli N Jr, Schwarzschild MA: Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease. J Neurosci 21: RC143, 2001
16. Fick GM, Gabow PA: Natural history of autosomal dominant polycystic kidney disease. Annu Rev Med 45: 23-29, 1994
17. Fredholm B: Are methylxanthine effects due to antagonism of endogenous adenosine? Tends Pharmacol Sci 1: 129-132, 1980
18. Hanaoka K, Guggino WB: cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. J Am Soc Nephrol 11: 1179-1187, 2000
19. Matousovic K, Tsuboi Y, Walker H, Grande JP, Dousa TP: Inhibitors of cyclic nucleotide phosphodiesterase isozymes block renal tubular cell proliferation induced by folic acid. J Lab Clin Med 130: 487-495, 1997
20. Erhardt P, Troppmair J, Rapp UR, Cooper GM: Differential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells. Mol Cell Biol 15: 5524-5530, 1995
21. Vossler MR, Yao H, York RD, Grande JP, Dousa TP.: cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 89: 73-82, 1997
22. Butcher RW, Ho RJ, Meng HC, Sutherland EW: Adenosine 3′,5′-monophosphate in biological materials. II: The measurement of adenosine 3′,5′-monophosphate in tissues and the role of the cyclic nucleotide in the lipolytic response of fat to epinephrine. J Biol Chem 240: 4515-4523, 1965
23. Butcher RW, Sneyd JG, Park CR, Sutherland EW: Effect of insulin on adenosine 3′,5′-monophosphate in the rat epididymal fat pad. J Biol Chem 241: 1651-1653, 1966
24. Butcher RW, Sutherland EW: The effects of the catecholamines, adrenergic blocking agents, prostaglandin E1, and insulin on cyclie AMP levels in the rat epididymal fat pad in vitro. Ann N Y Acad Sci 139: 849-859, 1967
25. Schwiebert EM, Wallace DP, Braunstein GM, King SR, Peti-Peterdi J, Hanaoka K, Guggino WB, Guay-Woodford LM, Bell PD, Sullivan LP, Grantham JJ, Taylor AL: Autocrine extracellular purinergic signaling in epithelial cells derived from polycystic kidneys. Am J Physiol Renal Physiol 282: F763-F775, 2002
26. Arend LJ, Sonnenburg WK, Smith WL, Spielman WS: A1 and A2 adenosine receptors in rabbit cortical collecting tubule cells. Modulation of hormone-stimulated cAMP. J Clin Invest 79: 710-714, 1987
27. i-dependent mechanism. Kidney Int 47: 1576-1584, 1995
28. Edwards RM, Spielman WS: Adenosine A1 receptor-mediated inhibition of vasopressin action in inner medullary collecting duct. Am J Physiol 266: F791-F796, 1994
29. Yamashita Y, Akaike N: Caffeine-induced chloride current in dissociated rat hepatocytes. Am J Physiol 270: C508-C513, 1996
30. Ye M, Grantham JJ: The secretion of fluid by renal cysts from patients with autosomal dominant polycystic kidney disease. N Engl J Med 329: 310-313, 1993
31. Gabow PA, Johnson AM, Kaehny WD, Manco-Johnson ML, Duley IT, Everson GT: Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 11: 1033-1037, 1990
32. Yamaguchi T, Nagao S, Kasahara M, Takahashi H, Grantham JJ: Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease. Am J Kidney Dis 30: 703-709, 1997
33. Nagao S, Yamaguchi T, Kusaka M, Maser R, Takahashi H, Cowley BD, Grantham JJ: Evidence of a role for the renal extracellular-regulated kinase (ERK) activation in rats with spontaneous autosomal dominant polycystic kidney disease (ADPKD). J Am Soc Nephrol 12: 541A, 2001
34. Chatterjee S, Shi WY, Wilson P, Mazumdar A: Role of lactosylceramide and MAP kinase in the proliferation of proximal tubular cells in human polycystic kidney disease. J Lipid Res 37: 1334-1344, 1996
35. Bonati M, Latini R, Galletti F, Young JF, Tognoni G, Garattini S: Caffeine disposition after oral doses. Clin Pharmacol Ther 32: 98-106, 1982
36. Mumford GK, Benowitz NL, Evans SM, Kaminski BJ, Preston KL, Sannerud CA, Silverman K, Griffiths RR: Absorption rate of methylxanthines following capsules, cola and chocolate. Eur J Clin Pharmacol 51: 319-325, 1996
37. Lelo A, Birkett DJ, Robson RA, Miners JO: Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man. Br J Clin Pharmacol 22: 177-182, 1986